Answers are grounded in this paper and cite their sources.
Molecular representation determines which aspects of chemical structure can be learned, compared, and interpreted in computational drug discovery. Existing encodings typically emphasize either compact string description, as in SMILES and SELFIES, or efficient similarity search, as in circular fingerprints. Although canonical SMILES already provides a deterministic string, its tokens are variable in width and carry no fixed chemical role. No existing representation simultaneously offers fixed-width, role-assigned tokenization, graph-level interpretability, pharmacophore annotation, and high-fidelity molecular reconstruction. Here, we introduce MolCodon, a codon-based molecular language that represents small molecules as deterministic sequences of fixed-width three-character tokens over a five-symbol alphabet, C, N, O, S, and X. Inspired by the triplet organization of the genetic code, MolCodon assigns chemically defined codon families to atoms, bonds, ring and branch topology, fused-ring references, pharmacophore features, bond mobility, charge, and stereochemistry. A deterministic graph traversal with ring-contiguity preservation produces sequences in which chemically meaningful substructures remain locally organized and traceable to the underlying molecular graph. Across approximately 2.9 million molecules from six commercial screening libraries, MolCodon achieved 98.93% InChIKey-level round-trip fidelity, supporting its use as a high-fidelity sequence representation for drug-like compounds. Across ten QSAR tasks, MolCodon-derived sparse sequence and trace features showed statistically supported advantages over the SMILES and SELFIES-based representations in most data sets while achieving competitive performance with classical fingerprints. These findings are supported by five repeated cross-validation and Tukey-adjusted pairwise comparisons. As an application of the representation, the MolCodon similarity engine decomposes molecular similarity into ring topology, branch context, attachment architecture, and pharmacophore correspondence, enabling interpretable scaffold-hopping searches. In a PARP1 virtual screening case study, MolCodon retrieved scaffold-diverse candidates using a known PARP-1 inhibitor Olaparib as the template compound. Together, these results establish MolCodon as a new molecular representation paradigm that transforms chemical graphs into high-fidelity, interpretable, and alignment-compatible codon sequences, opening a direct path for bioinformatics-inspired analysis of small-molecule chemical space. The MolCodon encoder, decoder, and similarity engine are freely available as open-source software at https://github.com/DurdagiLab/MolCodon.
No takes yet. Share an insight, caveat, or question.
Sayyah et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: